Whereas endothelial TGF-β signalling in atherosclerosis is pro-atherogenic, TGF-β, in the same atherosclerotic setting, has anti-inflammatory effects on smooth muscle cells (SMCs) and immune cells. This evidence concerns the gene TGFB1 and atherosclerosis.